Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Autor: | Lorenc ZP, Adelglass JM, Avelar RL, Baumann L, Beer KR, Cohen JL, Cox SE, Dayan SH, Dover JS, Downie JB, Draelos ZD, Goldman MP, Gross JE, Joseph JH, Kaufman-Janette J, Moy RL, Nestor M, Schlessinger J, Smith SR, Weiss RA |
---|---|
Jazyk: | angličtina |
Zdroj: | Aesthetic surgery journal [Aesthet Surg J] 2021 Nov 12; Vol. 41 (12), pp. 1494-1495. |
DOI: | 10.1093/asj/sjab230 |
Databáze: | MEDLINE |
Externí odkaz: |